Professor Peter Sasieni

Optimising cancer screening

Professor Peter Sasieni is the Academic Director of the Kings Clinical Trials Unit at King's College London. He is an expert in cancer prevention, clinical trials and cancer screening, and his work influences both policy and practice.

Screening can save lives by spotting cancers at an early stage, when they are easier to treat, and in some cases even prevent cancer from developing.

But screening is not perfect. The tests can miss cancers, and have other risks too. Professor Sasieni’s research is helping to identify the benefits and harms of the UK screening programmes – breast, cervix and bowel – and finding ways to improve them. And by studying cancer trends, his work can shed light on how public health policies such as these could affect future populations. His group is also researching potential new screening tests, for example to spot pre-cancer changes in the oesophagus. They’re also investigating whether personalised screening programmes could help keep a closer eye on patients with a higher risk of getting cancer, and result in decreased monitoring for those at low-risk.

Alongside this important work, Professor Sasieni heads important clinical trials in cancer prevention and screening. These address a broad range of cancers and subjects, from preventing oesophageal and breast cancers to developing of new ways to help people stop smoking.

Professor Sasieni’s work will have far-reaching implications, underpinning important changes in public health policy and practice that could improve early cancer detection and reduce the number of people affected by the disease.

See Professor Sasieni discussing cervical cancer screening and prevention here

Bowel (colorectal) cancer
Breast cancer
Cervical cancer
Oesophageal cancer
Cancer prevention
Statistics and methodology

Innovation Hub, Guy's Cancer Centre, Guy’s Hospital, Great Maze Pond, London, SE1 9RT